• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FANCD2 促进子宫内膜癌细胞的恶性行为及其预后价值。

FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.

机构信息

Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.

Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.

出版信息

Exp Cell Res. 2022 Dec 15;421(2):113388. doi: 10.1016/j.yexcr.2022.113388. Epub 2022 Oct 15.

DOI:10.1016/j.yexcr.2022.113388
PMID:36257352
Abstract

Defective DNA damage repair is a key mechanism affecting tumor susceptibility, treatment response, and survival outcome of endometrial cancer (EC). Fanconi anemia complementation group D2 (FANCD2) is the core component of the Fanconi anemia repair pathway. To explore the function of FANCD2 in EC, we examined the expression of FANCD2 in human specimens and databases, and discussed the possible mechanism of carcinogenesis by in vitro assays. Immunohistochemistry results showed overexpression of FANCD2 was detected in EC tissues compared to normal and atypical hyperplasia endometrium. Higher FANCD2 expression was correlated with deeper myometrial invasion (MI) and proficient mismatch repair status. The Cancer Genome Atlas (TCGA) database analysis showed FANCD2 was upregulated in EC compared with normal tissue. The high expression of FANCD2 was associated with poor overall survival in EC. Knockdown of FANCD2 expression in EC cell lines inhibited malignant proliferation and migration ability. We demonstrated that decreased FANCD2 expression results in increased DNA damage and decreased S-phase cells, leading to a decrease in proliferative capacity in EC cells. Down-regulated FANCD2 confers sensitivity of EC cells to interstrand crosslinking agents. This study provides evidence for the malignant progression and prognostic value of FANCD2 in EC.

摘要

DNA 损伤修复缺陷是影响子宫内膜癌(EC)易感性、治疗反应和生存结局的关键机制。范可尼贫血互补组 D2(FANCD2)是范可尼贫血修复途径的核心组成部分。为了探讨 FANCD2 在 EC 中的功能,我们检测了人类标本和数据库中 FANCD2 的表达,并通过体外实验探讨了其致癌的可能机制。免疫组化结果显示,与正常和非典型增生子宫内膜相比,EC 组织中 FANCD2 表达上调。较高的 FANCD2 表达与更深的肌层浸润(MI)和错配修复功能完整相关。癌症基因组图谱(TCGA)数据库分析显示,与正常组织相比,EC 中 FANCD2 表达上调。FANCD2 的高表达与 EC 患者的总生存率降低相关。在 EC 细胞系中敲低 FANCD2 的表达抑制了恶性增殖和迁移能力。我们证明,FANCD2 表达下调导致 DNA 损伤增加和 S 期细胞减少,从而降低 EC 细胞的增殖能力。下调 FANCD2 可使 EC 细胞对链间交联剂敏感。本研究为 FANCD2 在 EC 中的恶性进展和预后价值提供了证据。

相似文献

1
FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.FANCD2 促进子宫内膜癌细胞的恶性行为及其预后价值。
Exp Cell Res. 2022 Dec 15;421(2):113388. doi: 10.1016/j.yexcr.2022.113388. Epub 2022 Oct 15.
2
Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.通过DNA2解旋酶/核酸酶防止过度切除可抑制范科尼贫血细胞中的修复缺陷。
Cell Cycle. 2014;13(10):1540-50. doi: 10.4161/cc.28476. Epub 2014 Mar 12.
3
FANCD2 and DNA Damage.范可尼贫血互补组D2蛋白与DNA损伤
Int J Mol Sci. 2017 Aug 19;18(8):1804. doi: 10.3390/ijms18081804.
4
A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.范可尼贫血(FA)通路效应蛋白 FANCD2 在未转化的原代人细胞细胞周期进程中的新作用。
Cell Cycle. 2010 Jun 15;9(12):2375-88. doi: 10.4161/cc.9.12.11900.
5
Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway.范可尼贫血互补群 D2 通过抑制铁死亡通路促进子宫内膜癌细胞对化疗药物的敏感性。
BMC Womens Health. 2024 Jan 13;24(1):41. doi: 10.1186/s12905-023-02857-4.
6
The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization.范可尼贫血蛋白FANCD2和FANCJ相互作用并调节彼此的染色质定位。
J Biol Chem. 2014 Sep 12;289(37):25774-82. doi: 10.1074/jbc.M114.552570. Epub 2014 Jul 28.
7
Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in human tumors.泛癌症分析范可尼贫血互补组 D2(FANCD2)在人类肿瘤中的致瘤作用。
Genomics. 2024 Jan;116(1):110762. doi: 10.1016/j.ygeno.2023.110762. Epub 2023 Dec 15.
8
The ubiquitination machinery of the Fanconi Anemia DNA repair pathway.范可尼贫血症 DNA 修复途径的泛素化机制。
Prog Biophys Mol Biol. 2021 Aug;163:5-13. doi: 10.1016/j.pbiomolbio.2020.09.009. Epub 2020 Oct 12.
9
Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.早幼粒细胞白血病蛋白调节范可尼贫血基因表达。
Int J Mol Sci. 2021 Jul 21;22(15):7782. doi: 10.3390/ijms22157782.
10
Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.超越链间交联修复:FANCD2及其他范可尼贫血蛋白对DNA复制的作用
Mutat Res. 2018 Mar;808:83-92. doi: 10.1016/j.mrfmmm.2017.09.004. Epub 2017 Sep 14.

引用本文的文献

1
Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review).范可尼贫血通路在子宫内膜癌发病机制中的潜在作用(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13660. Epub 2025 Aug 24.
2
Pancreatic Neuroendocrine Tumor: The Case Report of a Patient with Germline Mutation and Tumor Analysis Using Single-Cell RNA Sequencing.胰腺神经内分泌肿瘤:一例携带种系突变患者的病例报告及单细胞RNA测序肿瘤分析
J Clin Med. 2024 Dec 14;13(24):7621. doi: 10.3390/jcm13247621.
3
Expression Analysis of FANCD2 in Endometrial Carcinoma.
FANCD2在子宫内膜癌中的表达分析
Cancer Manag Res. 2024 Dec 5;16:1715-1725. doi: 10.2147/CMAR.S488275. eCollection 2024.
4
Identification of the ferroptosis-related gene signature and the associated regulation axis in lung cancer and rheumatoid arthritis.鉴定肺癌和类风湿关节炎中的铁死亡相关基因特征及其相关调控轴。
Genes Immun. 2024 Oct;25(5):367-380. doi: 10.1038/s41435-024-00287-2. Epub 2024 Jul 29.
5
Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival.泛癌症分析 FANCD2 的预后和免疫作用:致癌和生存的潜在靶点。
BMC Med Genomics. 2024 Mar 5;17(1):69. doi: 10.1186/s12920-024-01836-4.
6
Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma.一种用于预测子宫内膜癌预后、免疫及药物敏感性的新型DNA损伤修复相关长链非编码RNA特征的开发与验证
Comput Struct Biotechnol J. 2023 Oct 14;21:4944-4959. doi: 10.1016/j.csbj.2023.10.025. eCollection 2023.
7
FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma.FANCD2 作为一种新型的预后生物标志物,与乙型肝炎相关肝细胞癌的免疫治疗和药物治疗相关。
Eur J Med Res. 2023 Oct 11;28(1):419. doi: 10.1186/s40001-023-01411-0.
8
Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.鉴定与子宫内膜癌进展和预后相关的新型关键基因。
Ann Transl Med. 2023 Jan 31;11(2):100. doi: 10.21037/atm-22-6461.